HealthBanks SmartParenting Genetic Testing

HealthBanks SmartParenting Genetic Testing for expecting parents and newborns

HealthBanks is proud to offer SmartParenting Genetic Testing to protect the health of your newborn. Our carrier and newborn genetic testing services can help uncover the genetic conditions that could be passed on to your child and identify potential health risks for your infant before symptoms arises.

Carrier Genetic Testing

Newborn Genetic Testing

Carrier Genetic Testing

A healthy baby begins with healthy genes. Yours!

Even if you don’t have family history of a genetic condition, you may carry a risk of passing one on to your children

Samples Collected from: Dad or Pregnant mom

30 Genes for Mom and 28 genes for Dad, Test coverage: 99% at 20x Del/Dup > 2 Exon

Screens for autosomal recessive and X-linked conditions: Cystic Fibrosis, Muscular Dystrophy, Hemoglobinopathies, Spinal Muscular Atrophy (SMA)Fragile X, Duchenne

Newborn Genetic Testing

Identify DNA changes that could cause severe or life-altering symptoms in an infant

Analyze 255 genes and over 200 conditions

Clear and concise reporting of diagnostic results that are medically actionable

Results are provided directly to your pediatrician or provider with clear follow-up recommendations

Target Conditions include: Metabolic, Blood & Immunodeficiency Disorders, Hearing & Vision Loss, Cardiac Conditions, Pediatric Cancers, Epilepsy, and others

Call Your Stem Cell Consultant today at 1-888-379-2670 to find out more information.

lgbtq flag

Subscribe to Our Newsletter & Special Promotions

Disclaimer: The use of cord blood and immune cells is determined by the treating physician and manufacturer of the final products and is influenced by many factors, including the patient's medical condition, the characteristics of the sample, and whether the immune cells should be further modified or expanded. Cord blood has established uses in transplant medicine; however, its use in regenerative medicine is still being researched. There is no guarantee that potential medical applications being studied in the laboratory or clinical trials will become available. Cord tissue use is still in early research stages, and there is no guarantee that treatments using cord tissue will be available in the future. Cord tissue is stored whole. Additional processing prior to use will be required to extract and prepare any of the multiple cell types from cryopreserved cord tissue. Immune cells has established uses in certain blood cancer treatment; however, its use in solid cancer is still being researched. There is no guarantee that treatments being studied in the laboratory, clinical trials, or other experimental treatments will be available in the future.

HealthBanks cryopreserves immune cells that have been collected from an individual for potential future cellular therapy use. HealthBanks does not provide medical advice, treatment or care. The use of cryopreserved cells for future immunotherapies is not guaranteed. Much is yet unknown about the future of immunotherapy and the immune cells that have been cryopreserved. The use of cryopreserved cells by commercial manufacturers for CAR-T therapy production is not currently approved by the FDA. There is active research ongoing, however, there is no guarantee that your cryopreserved cells will have a future therapeutic use. Only your health care professional can help you evaluate whether your cells might be used and if so, how they might be used. HealthBanks and its shareholders, directors, officers, agents, employees, affiliates, network of providers and provider facilities, will not be liable to you or any other party for claims relating to sample collection or if your cells cannot be used, or if any harm, injury, damage or loss results from the use of your cells. For more information, please refer to HealthBanks Service Agreement.

*Price Match is based on the same technology and service scope.